Our Technology: Thinking Globally
With just a few short years under our belts, Medgene Labs has developed several important patented, patent-pending and proprietary systems and products related to animal vaccines. These include:
- Exclusive, world-wide licensed vaccine technologies for Rift Valley Fever from the Department of Homeland Security's Center of Excellence for Emerging and Zoonotic Animal Diseases.
- A patent-pending in vitro vaccine screening system and subunit vaccine production system that leverage new USDA-CVB guidelines for licensing platform technologies, known as RapidxTM.
- Patented airborne pathogen collection system and proprietary bioinformatics approaches for disease surveillance.
- Exclusive, world-wide license for porcine epidemic diarrhea virus spike-proteins and monoclonal antibodies.
- Exclusive, world-wide license for vaccine adjuvants and delivery systems including InActTM, NaturprozTM, NaturmiczTM, and others.